Cited 0 time in
강직성척추염의 치료
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 허민영 | - |
| dc.contributor.author | 신동혁 | - |
| dc.contributor.author | 김태환 | - |
| dc.date.accessioned | 2022-12-21T11:48:56Z | - |
| dc.date.available | 2022-12-21T11:48:56Z | - |
| dc.date.issued | 2006-03 | - |
| dc.identifier.issn | 2093-940X | - |
| dc.identifier.issn | 2233-4718 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/181668 | - |
| dc.description.abstract | The conventional approach to treatment of patients with ankylosing spondylitis (AS) have been rather limited in the last decades. Evidence is accumulating that tumor necrosis factor (TNF) blocker is highly effective in AS. This article reviews the most recent and the most pertinent advances in the treatment in AS. TNF blocker have been evaluated in a number of randomized controlled trials in AS and have been demonstrated to be effective in disease activity, function, and quality of life in these patients. TNF blocker is emerging as the best therapeutic option available for patients with AS. | - |
| dc.format.extent | 9 | - |
| dc.language | 한국어 | - |
| dc.language.iso | KOR | - |
| dc.publisher | 대한류마티스학회 | - |
| dc.title | 강직성척추염의 치료 | - |
| dc.title.alternative | Treatment of Ankylosing Spondylitis | - |
| dc.type | Article | - |
| dc.publisher.location | 대한민국 | - |
| dc.identifier.bibliographicCitation | 대한류마티스학회지, v.13, no.1, pp 1 - 9 | - |
| dc.citation.title | 대한류마티스학회지 | - |
| dc.citation.volume | 13 | - |
| dc.citation.number | 1 | - |
| dc.citation.startPage | 1 | - |
| dc.citation.endPage | 9 | - |
| dc.identifier.kciid | ART000999429 | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | kci | - |
| dc.subject.keywordAuthor | Ankylosing spodylitis | - |
| dc.subject.keywordAuthor | Treatment | - |
| dc.subject.keywordAuthor | Tumor necrosis factor blocker | - |
| dc.subject.keywordAuthor | Ankylosing spodylitis | - |
| dc.subject.keywordAuthor | Treatment | - |
| dc.subject.keywordAuthor | Tumor necrosis factor blocker | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
